<DOC>
	<DOCNO>NCT02996630</DOCNO>
	<brief_summary>Congenital heart disease ( CHD ) prevalent congenital malformation affect 1 100 newborn per year . Children CHD know risk population brain injury , neurodevelopmental alteration show time 50 % case . No adequate description exist type neurocognitive anomaly risk factor associate CHD , consequently prognostic marker may allow identification high-risk case available .</brief_summary>
	<brief_title>Assessing Neurodevelopment Congenital Heart Disease .</brief_title>
	<detailed_description>The main objective study : 1. describe neurodevelopmental outcome patient CHD 24 month age ; 2. identify subgroup poorer outcome ; 3. evaluate utility fetal postnatal diagnostic technique early detection patient risk alter neurological outcome . Seven Spanish referral center CHD include research network maternal child health currently participate prospective multicentric case-control coordinate study . Fetuses CHD ( transposition great artery , tetralogy Fallot , hypoplastic leave heart syndrome septal defect ) study 24 week gestation 2 year age . Diagnostic test repeat throughout study patient , fetal period 24 month age , include : fetal cerebral hemodynamic Doppler assessment , functional echocardiography , brain MRI , regional cerebral oxymetry , electroencephalography serum neurological cardiac biomarkers analysis . Neurodevelopmental assessment make 12 month age use age stage questionnaire ( ASQ ) 24 month age Bayley-III test . From data , statistical analysis select useful predictor damage ; combine create algorithms predict brain damage poor neurodevelopment . Once description make , proceed identify amongst result , child poorest neurological outcome remark possible common prenatal early life marker well CHD severity present . While advance early diagnosis postnatal management increase survival CHD child , worry long-term outcome , particularly neurodevelopmental disability , emerge key prognostic factor counsel pregnancy . Evidence available allow clinician assess neurological prognosis although open possibility find prenatal marker brain damage . Even though , prospective study perform . We present multicentric prospective study able recruit enough fetal CHD affect pregnancy obtain neurological prognostic tool .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Single pregnancy Major Congenital Heart Disease Informed Consent Signed Major extracardiac malformation Parental Refusal participate Maternal Chronic Disease Multiple Pregnancies</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>LVOTO</keyword>
	<keyword>Fallot</keyword>
	<keyword>Great Arteries Transposition</keyword>
</DOC>